|By PR Newswire||
|December 5, 2012 10:49 AM EST||
WHITE PLAINS, N.Y. and STANFORD, Calif., Dec. 5, 2012 /PRNewswire/ -- Stanford University School of Medicine has presented John Walter, CEO of The Leukemia & Lymphoma Society (LLS), with the 2012 Spirit of Hope Award for Outstanding Health Care Organization in recognition of LLS's 35 years of funding support to Stanford's researchers.
In the last 15 years alone, LLS has awarded more than $27 million in research grants to Stanford University investigators, who are at the forefront of discovering innovative diagnostics and treatments.
The event was hosted by one of Stanford's esteemed researchers, Beverly Mitchell, MD, director of Stanford Cancer Institute, who has made many significant contributions to LLS over the years. Dr. Mitchell currently leads an LLS Specialized Center of Research (SCOR), a program that funds teams of researchers representing different disciplines who are engaged in collaborative efforts to discover new approaches to treat patients with hematological malignancies.
Among their many cutting-edge projects, the team is testing a new targeted drug for patients with myelodysplastic syndromes (MDS), with a long-term goal of preventing the disease from advancing to acute myelogenous leukemia (AML). This same drug is being advanced in clinical trials by Onconova Therapeutics Inc., a partner in LLS's Therapy Acceleration Program, a strategic initiative to form corporate partnerships to advance sponsored research in the clinic.
Dr. Mitchell also served as a past chair of LLS's Medical and Scientific Advisory Committee and was a member of its national Board of Directors.
"It is truly a great honor for LLS to be recognized by a world-class research institution such as Stanford," Walter said. "For more than 35 years we have shared a commitment to advancing outstanding cancer research and transforming the most promising discoveries into treatments to help patients live better, longer lives."
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.
SOURCE The Leukemia & Lymphoma Society